PolyA polymerase (PAP) adds a polyA tail onto the 3'-end of RNAs without a nucleic acid template, using adenosine-5'-triphosphate (ATP) as a substrate. The mechanism for the substrate selection by eubacterial PAP remains obscure. Structural and biochemical studies of Escherichia coli PAP (EcPAP) revealed that the shape and size of the nucleobase-interacting pocket of EcPAP are maintained by an intra-molecular hydrogen-network, making it suitable for the accommodation of only ATP, using a single amino acid, Arg(197). The pocket structure is sustained by interactions between the catalytic domain and the RNA-binding domain. EcPAP has a flexible basic C-terminal region that contributes to optimal RNA translocation for processive adenosine 5'-monophosphate (AMP) incorporations onto the 3'-end of RNAs. A comparison of the EcPAP structure with those of other template-independent RNA polymerases suggests that structural changes of domain(s) outside the conserved catalytic core domain altered the substrate specificities of the template-independent RNA polymerases.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/j.str.2010.12.006 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
A route to prepare ribonucleoside triphosphates featuring a 3'-aminoxy (3'-O-NH ) removable blocking group is reported here. We then show that versions of two DNA polymerases, human DNA polymerase theta (Polθ) and mimiviral PrimPol, accept these triphosphates as substrates to add single nucleotides to an RNA primer under engineered conditions. Cleaving the O-N bond in the 3'-O-NH group within the extended primer regenerates the 3'-OH group, facilitating subsequent polymerase cycles that add a second, selected, nucleotide.
View Article and Find Full Text PDFA Massively Parallel Assay of TdT Mutants Yields Variants with Altered Nucleotide Insertion Biases.
ACS Synth Biol
October 2024
Department of Biomedical Engineering, University of California, Irvine, California 92697, United States.
Terminal deoxynucleotidyl transferase (TdT) is a unique DNA polymerase capable of template-independent extension of DNA. TdT's DNA synthesis ability has found utility in DNA recording, DNA data storage, oligonucleotide synthesis, and nucleic acid labeling, but TdT's intrinsic nucleotide biases limit its versatility in such applications. Here, we describe a multiplexed assay for profiling and engineering the bias and overall activity of TdT variants with high throughput.
View Article and Find Full Text PDFBase-modified adenosine-5'-triphosphate (ATP) analogues are highly sought after as building blocks for mRNAs and non-coding RNAs, for genetic code expansion or as inhibitors. Current synthetic strategies lack efficient and robust 5'-triphosphorylation of adenosine derivatives or rely on costly phosphorylation reagents. Here, we combine the efficient organic synthesis of base-modified AMP analogues with enzymatic phosphorylation by a promiscuous polyphosphate kinase 2 class III from an unclassified bacterium (EbPPK2) to generate a panel of C2-, N-, or C8-modified ATP analogues.
View Article and Find Full Text PDFIn-line RNA-based microreactor direct mass spectrometry for ultrasensitive and rapid assay of terminal deoxynucleotidyl transferase activity.
Talanta
November 2024
Department of Chemistry, Northeast Normal University, 5268 Renmin Street, Changchun, Jilin Province, 130024, China. Electronic address:
Article Synopsis
- Terminal deoxynucleotidyl transferase (TdT) is significant in the human immune system and is a potential biomarker for diagnosing leukemia, thus making its detection crucial for medical purposes.* -
- A new method using an RNA-based microreactor connected to mass spectrometry (MS) has been developed to detect TdT activity in leukemic cells with high sensitivity and accuracy.* -
- This innovative microreactor design allows for efficient signal amplification, needing only a small sample volume of 10 nL and surpassing existing detection methods by several orders of magnitude.*
Template-independent enzymatic synthesis of RNA oligonucleotides.
Nat Biotechnol
July 2024
Department of Genetics, Harvard Medical School, Boston, MA, USA.
RNA oligonucleotides have emerged as a powerful therapeutic modality to treat disease, yet current manufacturing methods may not be able to deliver on anticipated future demand. Here, we report the development and optimization of an aqueous-based, template-independent enzymatic RNA oligonucleotide synthesis platform as an alternative to traditional chemical methods. The enzymatic synthesis of RNA oligonucleotides is made possible by controlled incorporation of reversible terminator nucleotides with a common 3'-O-allyl ether blocking group using new CID1 poly(U) polymerase mutant variants.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!